Affiliation: Centre for Addiction and Mental Health
- Mecamylamine - a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disordersIngrid Bacher
University of Toronto, Department of Psychiatry, Faculty of Medicine, Toronto, Canada
Expert Opin Pharmacother 10:2709-21. 2009..These areas of investigation for mecamylamine are reviewed and recommendations for future research directions are proposed...
- Neuropsychological performance in patients with schizophrenia and controls as a function of cigarette smoking statusVictoria C Wing
Centre for Addiction and Mental Health CAMH, Schizophrenia Program Division of Addiction Psychiatry, Department of Psychiatry, University of Toronto, Toronto, ON, Canada
Psychiatry Res 188:320-6. 2011..Our findings suggest that smoking status and history differentially alters neuropsychological outcomes in schizophrenia compared to non-psychiatric controls, and that never-smokers may present with more severe neurocognitive impairments...
- Monoamine oxidase A binding in the prefrontal and anterior cingulate cortices during acute withdrawal from heavy cigarette smokingIngrid Bacher
Vivian M Rakoff PET Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, 250 College St, Toronto, ON, Canada
Arch Gen Psychiatry 68:817-26. 2011..Dysphoria during cigarette withdrawal predicts relapse. It is unknown whether MAO-A binding increases during early cigarette withdrawal...
- Mechanisms underlying the comorbidity of tobacco use in mental health and addictive disordersDominique Morisano
Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, Ontario
Can J Psychiatry 54:356-67. 2009....